Correlation of circulating glucocorticoid-induced tnfr-related protein ligand levels with disease activity in patients with systemic lupus erythematosus

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Gu, Lei ^a   Xu, Lingxiao ^a   Zhang, Xiaojun ^a   Tan, Wenfeng ^a   Wang, Hong ^a   Zhang, Miaojia ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; DOUBLE STRANDED DNA ANTIBODY; GLUCOCORTICOID; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEIN LIGAND; IMMUNOGLOBULIN M; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; LIGAND; TNFSF18 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; SEVERITY OF ILLNESS INDEX;

ADULT; BLOOD SEDIMENTATION; CASE-CONTROL STUDIES; COMPLEMENT C3; FEMALE; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; HUMANS; IMMUNOGLOBULIN M; LIGANDS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTORS;

EID: 84871364036     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/265868     Document Type: Article

References (33)

1. Croker J. A., Kimberly R. P., SLE: challenges and candidates in human disease. Trends in Immunology 2005 26 11 580 586 2-s2.0-28444457777 10.1016/j.it.2005.09.001 (Pubitemid 41726445)
2. + regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunology 2002 3 2 135 142 2-s2.0-0036170938 10.1038/ni759 (Pubitemid 34141443)
3. + Immunoregulatory T Cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002 16 2 311 323 2-s2.0-0036195161 10.1016/S1074-7613(02)00280-7 (Pubitemid 34211969)
4. + T cells of patients with inflammatory bowel disease. Digestive Diseases and Sciences 2006 51 1 178 184 2-s2.0-30844448404 10.1007/s10620-006-3105-3 (Pubitemid 43106358)
5. Ronchetti S., Zollo O., Bruscoli S., Agostini M., Bianchini R., Nocentini G., Ayroldi E., Riccardi C., Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. European Journal of Immunology 2004 34 3 613 622 2-s2.0-1642379813 10.1002/eji.200324804 (Pubitemid 39255908)
6. Bae E., Kim W. J., Kang Y. M., Suk K., Koh E. M., Cha H. S., Ahn K. S., Huh T. L., Lee W. H., Glucocorticoid-induced tumour necrosis factor receptor-related protein-mediated macrophage stimulation may induce cellular adhesion and cytokine expression in rheumatoid arthritis. Clinical and Experimental Immunology 2007 148 3 410 418 2-s2.0-34247863712 10.1111/j.1365-2249.2007.03363.x (Pubitemid 46701026)
7. Nakae S., Suto H., Berry G. J., Galli S. J., Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood 2007 109 9 3640 3648 2-s2.0-34247401706 10.1182/blood-2006-09-046128 (Pubitemid 46641710)
8. Baltz K. M., Krusch M., Baessler T., Schmiedel B. J., Bringmann A., Brossart P., Salih H. R., Neutralization of tumor-derived soluble Glucocorticoid-Induced TNFR-related protein ligand increases NK cell anti-tumor reactivity. Blood 2008 112 9 3735 3743 2-s2.0-55749098643 10.1182/blood-2008-03- 143016
9. Chen S., Ndhlovu L. C., Takahashi T., Takeda K., Ikarashi Y., Kikuchi T., Murata K., Pandolfi P. P., Riccardi C., Ono M., Sugamura K., Ishii N., Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells. European Journal of Immunology 2008 38 8 2229 2240 2-s2.0-51149101887 10.1002/eji.200838167
10. + T cells. Journal of Immunology 2004 173 8 5008 5020 2-s2.0-6344279933 (Pubitemid 39387783)
11. Cardona I. D., Goleva E., Ou L. S., Leung D. Y. M., Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. Journal of Allergy and Clinical Immunology 2006 117 3 688 695 2-s2.0-33644777428 10.1016/j.jaci.2005.11.037 (Pubitemid 43340237)
12. Nocentini G., Ronchetti S., Petrillo M. G., Pharmacological modulation of GITRL/GITR system: therapeutic perspectives. British Journal of Pharmacology 2012 165 7 2089 2099
13. Azuma M., Role of the glucocorticoid-induced TNFR-related protein (GITR)-GITR ligand pathway in innate and adaptive immunity. Critical Reviews in Immunology 2010 30 6 547 557 2-s2.0-78650091928
14. Kamimura Y., Iwai H., Piao J., Hashiguchi M., Azuma M., The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity. Journal of Immunology 2009 182 5 2708 2716 2-s2.0-64849091216 10.4049/jimmunol.0803704
15. Avogadri F., Yuan J., Yang A., Schaer D., Wolchok J. D., Modulation of CTLA-4 and GITR for cancer immunotherapy. Current Topics in Microbiology and Immunology 2011 344 211 244 2-s2.0-79959790439 10.1007/82-2010-49
16. Burckhart T., Thiel M., Nishikawa H., Wüest T., Müller D., Zippelius A., Ritter G., Old L., Shiku H., Renner C., Tumor-specific crosslinking of GITR as costimulation for immunotherapy. Journal of Immunotherapy 2010 33 9 925 934 2-s2.0-78149284338 10.1097/CJI.0b013e3181f3cc87
17. Schaer D. A., Murphy J. T., Wolchok J. D., Modulation of GITR for cancer immunotherapy. Current Opinion in Immunology 2012 24 2 217 224
18. Buechele C., Baessler T., Wirths S., Glucocorticoid-induced TNFR-related protein (GITR) ligand modulates cytokine release and NK cell reactivity in chronic lymphocytic leukemia (CLL). Leukemia 2012 26 5 991 1000
19. Patel M., Xu D., Kewin P., Choo-Kang B., McSharry C., Thompson N. C., Liew F. Y., Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis. European Journal of Immunology 2005 35 12 3581 3590 2-s2.0-29744441207 10.1002/eji.200535421 (Pubitemid 43025538)
20. Cuzzocrea S., Ayroldi E., Di Paola R., Agostini M., Mazzon E., Bruscoli S., Genovese T., Ronchetti S., Caputi A. P., Riccardi C., Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis. The FASEB Journal 2005 19 10 1253 1265 2-s2.0-23444462753 10.1096/fj.04-3556com (Pubitemid 41113722)
21. Wang S., Shi Y., Yang M., Glucocorticoid-induced tumor necrosis factor receptor family-related protein exacerbates collagen-induced arthritis by enhancing the expansion of Th17 cells. The American Journal of Pathology 2012 180 3 1059 1067
22. Hochberg M. C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 1997 40 9 1725 2-s2.0-0031229830
23. Quan L. Z., Xie C., Wu T., Mackay M., Aranow C., Putterman C., Mohan C., Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. Journal of Clinical Investigation 2005 115 12 3428 3439 2-s2.0-31044440224 10.1172/JCI23587 (Pubitemid 43121831)
24. + regulatory T cells. Current Opinion in Immunology 2004 16 2 203 208 2-s2.0-1542368420 10.1016/j.coi.2004.01.004 (Pubitemid 38332029)
25. + T cells. Current Opinion in Immunology 2003 15 6 690 696 2-s2.0-0242407713 10.1016/j.coi.2003.09.011 (Pubitemid 37434077)
26. - 4high T regulatory cells with target (allo)antigen specificity. Journal of Immunology 2004 173 4 2866 2876 2-s2.0-4043140730 (Pubitemid 39063149)
27. + regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer. Hepatology. In press 1002/hep.26013
28. Crispin J. C., Martínez A., Alcocer-Varela J., Quantification of regulatory T cells in patients with systemic lupus erythematosus. Journal of Autoimmunity 2003 21 3 273 276 2-s2.0-0242403301 10.1016/S0896-8411(03)00121-5 (Pubitemid 37410115)
29. Nocentini G., Ronchetti S., Cuzzocrea S., Riccardi C., GITR/GITRL: more than an effector T cell co-stimulatory system. European Journal of Immunology 2007 37 5 1165 1169 2-s2.0-34250341733 10.1002/eji.200636933 (Pubitemid 46925300)
30. + regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunology 2002 3 2 135 142 2-s2.0-0036170938 10.1038/ni759 (Pubitemid 34141443)
31. Hiraki L. T., Benseler S. M., Tyrrell P. N., Hebert D., Harvey E., Silverman E. D., Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. The Journal of Pediatrics 2008 152 4 550 556 2-s2.0-40749094379 10.1016/j.jpeds.2007.09.019 (Pubitemid 351381032)
32. La Cava A., Fang C. J., Singh R. P., Ebling F., Hahn B. H., Manipulation of immune regulation in systemic lupus erythematosus. Autoimmunity Reviews 2005 4 8 515 519 2-s2.0-26244450587 10.1016/j.autrev.2005.04.008 (Pubitemid 41415762)
33. + T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis. Nephrology Dialysis Transplantation 2009 24 1 161 171 2-s2.0-58049215481 10.1093/ndt/gfn461